Pharma

Times

Virupaksha Organics Ltd. has established itself as a trusted name in the global pharmaceutical market, specializing in the production of Fluconazole, a critical antifungal medication used to treat a wide range of fungal infections. With state-of-the-art manufacturing facilities located in Telangana, India, the company adheres to the highest standards of quality, safety, and regulatory compliance to produce high-purity Fluconazole for both domestic and international markets.

Fluconazole is widely prescribed to treat conditions like candidiasis and cryptococcal meningitis, and Virupaksha Organics’ commitment to producing this essential API ensures a reliable supply to healthcare providers worldwide. The company’s facilities are WHO-GMP, ISO 9001, and ISO 14001 certified, reflecting its dedication to maintaining excellence in manufacturing while also being environmentally conscious.

By leveraging cutting-edge technology and a robust research and development process, Virupaksha continues to meet the growing global demand for Fluconazole, ensuring that patients receive effective and affordable treatment. As part of its mission to be a research-driven pharmaceutical company, Virupaksha Organics remains a trusted partner for pharmaceutical companies around the globe, delivering high-quality APIs with a focus on customer satisfaction and sustainability.

With its expanding global footprint, Virupaksha Organics Ltd. is poised to remain at the forefront of the pharmaceutical industry, particularly in the production of vital medications like Fluconazole, helping to combat fungal infections and improve health outcomes worldwide.

Latest Update

Latest Update

@ All Rights Reserved. Designed and Powered by PharmaTimes